Skip to main content
Fig. 3 | BMC Cardiovascular Disorders

Fig. 3

From: Bone marrow-derived mesenchymal stem cells attenuate myocardial ischemia–reperfusion injury via upregulation of splenic regulatory T cells

Fig. 3

Cardiac infiltrating cells and cardiomyocyte disruption were reduced after BM-MSCs treatment in MIRI mice. Images (200×) of HE-stained myocardium sections of representative MIRI mice treated with IgG, IgG + BM-MSCs, PC61, PC61 + BM-MSCs, splenectomy, and splenectomy + BM-MSCs are shown. The hearts were collected 72 h after surgically-induced MIRI. Arrows indicate the mononuclear cells. The scalebar shown in the lower right corner of each image represents 50 μm. BM-MSCs, bone marrow-derived mesenchymal stem cells; MIRI, myocardial ischemia–reperfusion injury

Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us